{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:53:00Z","timestamp":1769907180391,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00277-020-04283-0","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T23:04:50Z","timestamp":1601507090000},"page":"2911-2925","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Unmanipulated haplo-identical donor transplantation compared with identical sibling donor had better anti-leukemia effect for refractory\/relapsed acute myeloid leukemia not in remission status"],"prefix":"10.1007","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6827-8146","authenticated-orcid":false,"given":"Yue","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing-Yu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Juan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Jie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dao-Pei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"key":"4283_CR1","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1182\/blood-2005-05-2146","volume":"107","author":"D-P Lu","year":"2006","unstructured":"Lu D-P, Dong L, Wu T, Huang X-J, Zhang M-J, Han W et al (2006) Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched\/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood 107:3065\u20133073","journal-title":"Blood"},{"key":"4283_CR2","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1182\/blood-2015-02-627786","volume":"125","author":"Y Wang","year":"2015","unstructured":"Wang Y, Liu QF, Xu LP, Liu KY, Zhang XH, Ma X, Fan ZP, Wu DP, Huang XJ (2015) Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study. Blood 125:3956\u20133962","journal-title":"Blood"},{"key":"4283_CR3","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1200\/JCO.2012.44.3523","volume":"31","author":"A Bashey","year":"2013","unstructured":"Bashey A, Zhang X, Sizemore CA, Manion K, Brown S, Holland HK, Morris LE, Solomon SR (2013) T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation. J Clin Oncol 31:1310\u20131316","journal-title":"J Clin Oncol"},{"key":"4283_CR4","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.bbmt.2014.05.029","volume":"20","author":"AM Raiola","year":"2014","unstructured":"Raiola AM, Dominietto A, di Grazia C, Lamparelli T, Gualandi F, Ibatici A, Bregante S, van Lint MT, Varaldo R, Ghiso A, Gobbi M, Carella AM, Signori A, Galaverna F, Bacigalupo A (2014) Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts. Biol Blood Marrow Transplant 20:1573\u20131579","journal-title":"Biol Blood Marrow Transplant"},{"key":"4283_CR5","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1038\/leu.2015.98","volume":"29","author":"A Ruggeri","year":"2015","unstructured":"Ruggeri A, Labopin M, Sanz G, Piemontese S, Arcese W, Bacigalupo A et al (2015) Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia. Leukemia 29:1891\u20131900","journal-title":"Leukemia"},{"key":"4283_CR6","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.bbmt.2014.05.015","volume":"20","author":"M Eapen","year":"2014","unstructured":"Eapen M, O\u2019Donnell P, Brunstein CG, Wu J, Barowski K, Mendizabal A et al (2014) Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies. Biol Blood Marrow Transplant 20:1485\u20131492","journal-title":"Biol Blood Marrow Transplant"},{"key":"4283_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.bbmt.2010.08.023","volume":"17","author":"Y Wang","year":"2011","unstructured":"Wang Y, Liu DH, Xu LP, Liu KY, Chen H, Chen YH, Han W, Shi HX, Huang XJ (2011) Superior graft-versus-leukemia effect associated with transplantation of haploidentical compared with HLA-identical sibling donor grafts for high-risk acute leukemia: an historic comparison. Biol Blood Marrow Transplant 17:821\u2013830","journal-title":"Biol Blood Marrow Transplant"},{"key":"4283_CR8","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.leukres.2015.10.011","volume":"39","author":"N Liu","year":"2015","unstructured":"Liu N, Ning HM, Hu LD, Jiang M, Xu C, Hu JW et al (2015) Outcome of myeloablative allogeneic peripheral blood hematopoietic stem cell transplantation for refractory\/relapsed AML patients in NR status. Leuk Res 39:1375\u20131381","journal-title":"Leuk Res"},{"key":"4283_CR9","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.bbmt.2018.01.005","volume":"24","author":"R Dul\u00e9ry","year":"2018","unstructured":"Dul\u00e9ry R, M\u00e9nard AL, Chantepie S, El-Cheikh J, Fran\u00e7ois S, Delage J et al (2018) Sequential conditioning with thiotepa in T cell- replete hematopoietic stem cell transplantation for the treatment of refractory hematologic malignancies: comparison with matched related, Haplo-mismatched, and unrelated donors. Biol Blood Marrow Transplant 24:1013\u20131021","journal-title":"Biol Blood Marrow Transplant"},{"key":"4283_CR10","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1007\/s00277-018-3428-0","volume":"97","author":"B Gu","year":"2018","unstructured":"Gu B, Zhang X, Chen G, Wu X, Ma X, Chen S, Wu D (2018) Efficacy of haploidentical hematopoietic stem cell transplantation compared to HLA-matched transplantation for primary refractory acute myeloid leukemia. Ann Hematol 97:2185\u20132194","journal-title":"Ann Hematol"},{"key":"4283_CR11","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1200\/JCO.2010.28.8852","volume":"28","author":"M Duval","year":"2010","unstructured":"Duval M, Klein JP, He W, Cahn JY, Cairo M, Camitta BM, Kamble R, Copelan E, de Lima M, Gupta V, Keating A, Lazarus HM, Litzow MR, Marks DI, Maziarz RT, Rizzieri DA, Schiller G, Schultz KR, Tallman MS, Weisdorf D (2010) Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J Clin Oncol 28:3730\u20133738","journal-title":"J Clin Oncol"},{"key":"4283_CR12","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/leu.2011.13","volume":"25","author":"C Craddock","year":"2011","unstructured":"Craddock C, Labopin M, Pillai S, Finke J, Bunjes D, Greinix H, Ehninger G, Steckel NK, Zander AR, Schwerdtfeger R, Buchholz S, Kolb HJ, Volin L, Fauser A, Polge E, Schmid C, Mohty M, Rocha V (2011) Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia. Leukemia 25:808\u2013813","journal-title":"Leukemia"},{"key":"4283_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0268-960X(03)00040-7","volume":"18","author":"K Mr\u00f3zek","year":"2004","unstructured":"Mr\u00f3zek K, Heerema NA, Bloomfield CD (2004) Cytogenetics in acute leukemia. Blood Rev 18:115\u2013136","journal-title":"Blood Rev"},{"key":"4283_CR14","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1182\/blood-2003-02-0430","volume":"102","author":"Y Kanda","year":"2003","unstructured":"Kanda Y, Chiba S, Hirai H, Sakamaki H, Iseki T, Kodera Y, Karasuno T et al (2003) Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991\u20132000). Blood 102:1541\u20131547","journal-title":"Blood"},{"key":"4283_CR15","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1200\/JCO.1997.15.5.1767","volume":"15","author":"R Szydlo","year":"1997","unstructured":"Szydlo R, Goldman JM, Klein JP, Gale RP, Ash RC, Bach FH et al (1997) Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 15:1767\u20131777","journal-title":"J Clin Oncol"},{"key":"4283_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-016-0379-6","volume":"10","author":"YJ Chang","year":"2017","unstructured":"Chang YJ, Wang Y, Liu YR, Xu LP, Zhang XH, Chen H et al (2017) Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis. J Hematol Oncol 10:1\u201313","journal-title":"J Hematol Oncol"},{"key":"4283_CR17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1586\/ehm.10.32","volume":"3","author":"AJ Barrett","year":"2010","unstructured":"Barrett AJ, Battiwalla M (2010) Relapse after allogeneic stem cell transplantation. Expert Rev Hematol 3:429\u2013441","journal-title":"Expert Rev Hematol"},{"key":"4283_CR18","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1399-0012.2012.01626.x","volume":"26","author":"Y Wang","year":"2012","unstructured":"Wang Y, Liu DH, Fan ZP, Sun J, Wu XJ, Ma X, Xu LP, Liu KY, Liu QF, Wu DP, Huang XJ (2012) Prevention of relapse using DLI can increase survival following HLA-identical transplantation in patients with advanced-stage acute leukemia: a multi-center study. Clin Transpl 26:635\u2013643","journal-title":"Clin Transpl"},{"key":"4283_CR19","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/bmt.2011.213","volume":"47","author":"Y Wang","year":"2012","unstructured":"Wang Y, Liu DH, Xu LP, Liu KY, Chen H, Zhang XH, Chen YH, Han W, Wang FR, Wang JZ, Yan CH, Huang XJ (2012) Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched\/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysis. Bone Marrow Transplant 47:1099\u20131104","journal-title":"Bone Marrow Transplant"},{"key":"4283_CR20","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.1182\/blood-2007-02-072470","volume":"109","author":"A Dominietto","year":"2007","unstructured":"Dominietto A, Pozzi S, Miglino M, Albarracin F, Piaggio G, Bertolotti F, Grasso R, Zupo S, Raiola AM, Gobbi M, Frassoni F, Bacigalupo A (2007) Donor lymphocyte infusions for the treatment of minimal residual disease in acute leukemia [2]. Blood 109:5063\u20135064","journal-title":"Blood"},{"key":"4283_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1365-2141.2001.02551.x","volume":"112","author":"G Jackson","year":"2001","unstructured":"Jackson G, Taylor P, Smith GM, Marcus R, Smith A, Chu P, Littlewood TJ, Duncombe A, Hutchinson M, Mehta AB, Johnson SA, Carey P, Mackie MJ, Ganly PS, Turner GE, Deane M, Schey S, Brookes J, Tollerfield SM, Wilson MP (2001) A multicentre, open, non-comparative phase II study of a combination of fludarabine, cytarabine and G-CSF in relapsed and refractory AML and de novo RAEB-MDS. Br J Haematol 112:127\u2013137","journal-title":"Br J Haematol"},{"key":"4283_CR22","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1182\/blood.V89.11.4226","volume":"89","author":"J Sierra","year":"1997","unstructured":"Sierra J, Storer B, Hansen JA, Bjerke JW, Martin PJ, Petersdorf EW, Appelbaum FR, Bryant E, Chauncey TR, Sale G, Sanders JE, Storb R, Sullivan KM, Anasetti C (1997) Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood 89:4226\u20134235","journal-title":"Blood"},{"key":"4283_CR23","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3324\/haematol.2016.148825","volume":"101","author":"P Ferguson","year":"2016","unstructured":"Ferguson P, Hills RK, Grech A, Betteridge S, Kjeldsen L, Dennis M, Vyas P, Goldstone AH, Milligan D, Clark RE, Russell NH, Craddock C, UK NCRI AML Working Group (2016) An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation. Haematologica 101:1351\u20131358","journal-title":"Haematologica"},{"key":"4283_CR24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00432-015-2050-y","volume":"142","author":"C Pfrepper","year":"2016","unstructured":"Pfrepper C, Klink A, Behre G, Schenk T, Franke GN, Jentzsch M, Schwind S, al-Ali HK, Hochhaus A, Niederwieser D, Sayer HG (2016) Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation. J Cancer Res Clin Oncol 142:317\u2013324","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"4283_CR25","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/jcpt.12251","volume":"40","author":"C Zhang","year":"2015","unstructured":"Zhang C, Chen X, Mb JL, Gao L, Liu Y, Gao L et al (2015) Decitabine as a conditioning regimen in haploidentical stem cell transplantation for refractory acute myeloid leukaemia. J Clin Pharm Ther 40(3):336\u2013338","journal-title":"J Clin Pharm Ther"},{"issue":"2","key":"4283_CR26","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/bmt.2011.66","volume":"47","author":"M Hong","year":"2012","unstructured":"Hong M, Wu Q, Hu C, Fang J, You Y, Zhong Z, Zou P, Hu Y, Xia L (2012 Feb) Idarubicin-intensified BUCY2 regimens may lower relapse rate and improve survival in patients undergoing allo-SCT for high-risk hematological malignancies : a retrospective analysis. Bone Marrow Transplant 47(2):196\u2013202","journal-title":"Bone Marrow Transplant"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04283-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-020-04283-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04283-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T01:55:56Z","timestamp":1633053356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-020-04283-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4283"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-04283-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]},"assertion":[{"value":"12 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}